Five more manufacturers are licensed to produce drugs used to treat black fungus: Government | India News
Efforts are underway to supplement the national availability of the antifungal drug through importation, the ministry said, adding that 3.63,000 vials of amphotericin-B will be imported in May, resulting in the total availability of 5,26,752. roads (including national production) in the country.
He said 3.15,000 vials will be imported in June and, along with the national supply, the availability of amphotericin-B across the country will increase to 5,70,114 vials in June.
Several states and union territories have reported increasing numbers of patients suffering from COVID complications in recent days in the form of mucormycosis, popularly known as black fungus, the ministry said in a statement.
A shortage of amphotericin-B has also been reported, he said.
The Union Ministry of Health together with the Department of Pharmaceutical products Y Ministry of Foreign Affairs (ME) are making proactive efforts to significantly increase domestic amphotericin-B production, he said.
The Union government has also made effective efforts to supplement national availability by securing supply from global manufacturers, according to the statement.
The five manufacturers that have been licensed to produce amphotericin-B in the country are NATCO Pharmaceuticals, Hyderabad, Alembic Pharmaceuticals, Vadodara, Gufic Biosciences Ltd, Gujarat, Emcure Pharmaceuticals, Pune and Lyka in Gujarat.
These companies will start producing 1.11,000 vials of amphotericin-B per month starting in July this year, according to the statement.
The Union Ministry of Health and pharmaceuticals department Together they are trying to proactively facilitate these five manufacturers to prep some of this production for these additional supplies to begin in June, according to the statement.
There are five amphotericin B manufacturers in the country and one importer: Bharat Serums & Vaccines Ltd, BDR Pharmaceuticals Ltd, Sun Pharma Ltd, Cipla Ltd, Life Care Innovations and Mylan Labs (importer).
“The production capacity of these companies was extremely limited in April.
“As a result of the grasping of the hand by Government of India, these domestic manufactures will cumulatively produce 1.63,752 vials of amphotericin-B in May. This will be further increased to 2.55,114 vials in June, “the ministry said.
Efforts are also being made to supplement the national availability of this antifungal drug through importation, he said.
“In May, 3.63,000 vials of amphotericin-B will be imported, resulting in a total availability in the country (including national production) of 5,26,752 vials”
“In addition, 3.15,000 vials will be imported in June. Therefore, together with the national supply, the national availability of amphotericin-B will increase to 5,70,114 vials in June,” the ministry said.
Together, these companies will start producing 1.11,000 vials of amphotericin-B per month starting in July, he added.
The Union Ministry of Health In collaboration with MEA, it is also actively exploring other global sources from where the drug Amphotericin-B can be imported.
The ministry is also trying to procure other antifungal drugs that can be used to treat black fungus, the statement added.